ADAR1 Capital Management’s Relmada Therapeutics RLMD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$78K	Buy	+130,000	New	+$78K	0.01%	175
2024 Q3	–	Sell	-50,601	Closed	-$152K	–	302
2024 Q2	$152K	Buy	50,601 +50,000	+8,319%	+$150K	0.03%	147
2024 Q1	$2.8K	Sell	601 -58,000	-99%	-$270K	﹤0.01%	223
2023 Q4	$243K	Buy	+58,601	New	+$243K	0.09%	71